{"transactions":[{"id":3372509,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":148499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners Accredited Partnership III, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":148499,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":6014},"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}},{"id":3372508,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":148499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners QP Partnership III, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":148499},"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}},{"id":3372507,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":31168,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners Accredited Partnership III, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":31168,"derivative":{"exercise_price":28.65,"exercise_date":"2019-11-13","expiration_date":"2027-01-18","underlying":"Common Stock","underlying_shares":1262},"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}},{"id":3372506,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":31168,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners Accredited Partnership III, LP"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"Warrants exercisable for shares of Series B Preferred Stock automatically converted into warrants exercisable for shares of Common Stock upon the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":1.16,"exercise_date":"2017-01-18","expiration_date":"2027-01-18","underlying":"Series B Preferred Stock","underlying_shares":31168},"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}},{"id":3372505,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":7051009,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners QP Partnership III, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":285580},"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}},{"id":3372504,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":1479951,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners Accredited Partnership III, LP"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":59940},"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}},{"id":3372503,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":285580,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners QP Partnership III, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Reflects 219,701 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Reflects 1-for-24.69 reverse stock split which became effective on October 28, 2019."}],"balance_after":505281,"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}},{"id":3372502,"issuer":{"id":7381,"kind":"organization","name":"TELA Bio, Inc.","symbol":"TELA"},"owners":[{"id":153835,"kind":"person","name":"Friedman Ashley","position":1,"cik":"0001790193","reported_name":"Friedman Ashley","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-14T01:48:59.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":59940,"ownership":{"direct":false,"nature":"By Signet Healthcare Partners Accredited Partnership III, LP"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of Series B Preferred Stock automatically converted into shares of Common Stock at a 1-for-1 conversion rate upon the closing of the Issuer's initial public offering and had no expiration date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reflects 46,112 shares of common stock received as a payment-in-kind dividend on Series B Preferred Stock exempt from reporting under Rule 16a-9(a)."}],"balance_after":106052,"source":{"system":"sec-edgar","filing":"0001192482-19-000421","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1561921/000119248219000421/edgar.xml","form_type":"4"}}]}